Haemonetics Revenues Down $HAE $XHS
Haemonetics Inc., a Blood management Company, has announced its annual results for FY-2014. The results shows, Revenues down by 3% to $910.4 Million, Adjusted EPS went down by 15% to $1.85. View the full earnings release here.
Haemonetics Revenues Down $HAE $XHS Read More »